Sounding as if he were announcing an antivirus software update, Albert Bourla said as two doses of Pfizer’s Covid injection only offer “very limited protection, if any,” and three doses only offer reasonable protection against Omicron, Pfizer will have a new version of their injection, “version 1.1”, ready in March.
Bourla is a veterinarian and CEO of Pfizer. He is also one of the perpetrators of crimes against humanity named in a complaint filed with the International Criminal Court by a UK team.
“So– and we know that the two doses of the vaccine offer very limited protection, if any. The three doses, with the booster, they offer reasonable protection against hospitalisation and deaths– and, again, that’s, I think, very good– and less protection against the infection.
“Now, we are working on a new version of our vaccine– the 1.1, let me put it that way– that will cover Omicron as well. And, of course, we are waiting to have the final results. The vaccine will be ready in March. And the vaccine, we’ll be able to produce it massively,” Bourla told Yahoo Finance on Monday.
This contradicts a Pfizer press release a month earlier which announced: “Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech Covid-19 vaccine neutralise the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralisation titers.”